Published by Josh White on 25th February 2020
(Sharecast News) - AstraZeneca has agreed to sublicense its global rights to 'Movantik', or naloxegol, excluding Europe, Canada and Israel, to RedHill Biopharma, it announced on Tuesday.
URL: http://www.digitallook.com/dl/news/story/30291366/...